2014
DOI: 10.1007/s10072-014-1878-2
|View full text |Cite
|
Sign up to set email alerts
|

The association between the LRRK2 G2385R variant and the risk of Parkinson’s disease: a meta-analysis based on 23 case–control studies

Abstract: Clinical diagnosis of Parkinson's disease (PD) is essential but misdiagnosis of PD-like diseases is quite common. LRRK2 G2385R variants have been extensively examined for the association to the risk of Parkinson's disease. However, results from different studies are inconsistent. The purpose of this meta-analysis was to assess the association between the LRRK2 G2385R variants and the risk of PD. A systematic literature search was performed for 6 databases up to January of 2014 to identify case-control studies … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 45 publications
0
17
0
Order By: Relevance
“…Importantly, strong genetic association suggests that the missense substitution of glycine 2385 to arginine (G2385R) within the C-terminal WD40 domain is a pathologically relevant variant. The G2385R variant is associated with an increased risk of developing idiopathic PD in Chinese Han and Korean ethnicity 20–22 . We show here that the G2385R variant alters the LRRK2-associated protein interactome and reduces its binding to SV.…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, strong genetic association suggests that the missense substitution of glycine 2385 to arginine (G2385R) within the C-terminal WD40 domain is a pathologically relevant variant. The G2385R variant is associated with an increased risk of developing idiopathic PD in Chinese Han and Korean ethnicity 20–22 . We show here that the G2385R variant alters the LRRK2-associated protein interactome and reduces its binding to SV.…”
Section: Introductionmentioning
confidence: 99%
“…The used LRRK2 translational model most closely approximates human LRRK2 G2385R mutation, which occurs in the human WD40 domain and is a risk factor for PD, mainly in Asian populations [21]. …”
Section: Discussionmentioning
confidence: 99%
“…Two more common variations in the LRRK2 gene have been described: G2019S and G2385R [19]. Among them, the most common (G2019S) accounts for 3–6% of familial dominant PD and for 1-2% of sporadic forms with a north-south gradient of G2019S frequency in European countries and reaching frequency up to 41% in North African cases [20], while the second variation (G2385R) is common mainly in Asian populations [19, 21]. To date, apparent discrepancies between these variations have been reported, suggesting a more complicated phenotype in the G2385R mutation carriers than in LRRK2 G2019S mutation carriers [19].…”
Section: Introductionmentioning
confidence: 99%
“…5,6 The distribution of LRRK2 variants differs significantly among genetically diverse populations. 4,[7][8][9][10][11] The most commonly reported LRRK2 mutation, G2019S, accounts for~41% of PD in North African Arab-Berbers,~31% in Ashkenazi Jews with familial PD2, and is underrepresented in the Asian PD population. 7,12 Haplotype linkage disequilibrium studies suggest a common founder effect in these populations.…”
Section: Lrrk2mentioning
confidence: 99%